Principal Global Investors Files Schedule 13G/A for Castle Biosciences
A Schedule 13G/A for Castle Biosciences was filed by Principal Global Investors. The filing date is listed as October 29, 20.
Related stories
Aecon Group Reports Quarterly Results Through September 30
Aecon Group reported results for the quarter ended September 30. Figures are in Canadian dollars unless otherwise stated.
M impact | EQUITY | Oct 29, 2026, 11:58 PM UTC
Eastman Chemical Reports Quarterly Results Through September 30
The LSEG-generated earnings summary covers Eastman Chemical Co.'s quarter ended September 30.
M impact | EQUITY | Oct 29, 2026, 11:58 PM UTC
Coles Shares Fall 12% After Sales Disappoint, Fuel Costs Threaten Profits
Coles said supermarket same-store sales rose 2.7% in the 13 weeks through Sept. 27 and warned that rising fuel costs would hurt profits. Its shares fell 12%, putting them on course
M impact | EQUITY | Oct 29, 2026, 11:57 PM UTC
TFS Financial Reports Quarterly Results
TFS Financial Corp reported results for the quarter ended September 30.
M impact | EQUITY | Oct 29, 2026, 11:56 PM UTC
FirstCash Shares Decline 14.75% as Law Firm Investigates Potential Securities Fraud
The Law Offices of Frank R. Cruz says it continues investigating potential securities fraud after a 14.75% decline in FirstCash Holdings shares.
M impact | EQUITY | Oct 29, 2026, 11:56 PM UTC
First Northern Reports Higher Third-Quarter Net Profit
First Northern said net profit rose in the third quarter of 2026 compared with the previous quarter.
M impact | EQUITY | Oct 29, 2026, 11:56 PM UTC